Buchumschlag

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer

Androgen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question the predictive property of AR-Vs. From a mechanistic perspective, the connection between AR full length (AR-FL) and AR-Vs is not fully understood. Here, we aimed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wüstmann, Neele (Verfasst von) , Seitzer, Konstantin (Verfasst von) , Humberg, Verena (Verfasst von) , Vieler, Julia (Verfasst von) , Grundmann, Norbert (Verfasst von) , Steinestel, Julie (Verfasst von) , Tiedje, Dorothee (Verfasst von) , Duensing, Stefan (Verfasst von) , Krabbe, Laura-Maria (Verfasst von) , Bögemann, Martin (Verfasst von) , Schrader, Andres Jan (Verfasst von) , Bernemann, Christof (Verfasst von) , Schlack, Katrin (Verfasst von)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 05 April 2023
In: Biomarker Research
Year: 2023, Jahrgang: 11, Pages: 1-14
ISSN:2050-7771
DOI:10.1186/s40364-023-00481-w
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s40364-023-00481-w
Volltext
Verfasserangaben:Neele Wüstmann, Konstantin Seitzer, Verena Humberg, Julia Vieler, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Stefan Duensing, Laura-Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann and Katrin Schlack
Beschreibung
Zusammenfassung:Androgen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question the predictive property of AR-Vs. From a mechanistic perspective, the connection between AR full length (AR-FL) and AR-Vs is not fully understood. Here, we aimed to investigate the dependence of AR-FL and AR-V expression levels on AR gene activity. Additionally, we intended to comprehensively analyze presence of AR-FL and three clinically relevant AR-Vs (AR-V3, AR-V7 and AR-V9) in different stages of disease, especially with respect to clinical utility in PC patients undergoing AR targeted agent (ARTA) treatment.
Beschreibung:Gesehen am 17.05.2023
Beschreibung:Online Resource
ISSN:2050-7771
DOI:10.1186/s40364-023-00481-w

Ähnliche Einträge